Group I (Senning patients) N: 31 Group II (Controls) N: 30
P-value
Demographic characteristics: Demographic characteristics: Demographic characteristics: Demographic characteristics:
Age at Senning operation (months) 11.2 ± 1.30
Age at examination (years) 12.88 ± 3.12 12.50 ± 2.92 0.08
Weight (kg) 31.71 ± 9.17 33.18 ± 8.96 0.12
Gender: Male Female 20 (62.52 %) 11 (35.48 %) 15 (50.00 %) 15 (50.00 %)
Clinical data: Clinical data: Clinical data: Clinical data:
Symptoms at presentation: - None - Dyspnea - Chest infection - Arrhythmias 19 (61.29 %) 9 (29.03 %) 3 (9.68 %) 0 (0 %)
Hemodynamic data: Hemodynamic data: Hemodynamic data: Hemodynamic data:
Oxygen saturation (%) 97.75 ± 0.50 99.15 ± 0.76 0.04*
Heart rate (bpm) 98.45 ± 15.76 89.31 ±10.17 0.01*
Blood pressure (mmHg)
105.85 ± 13.31/ 71.75 ± 11.41 107.50 ± 14.55/ 72.00 ± 10.24
0. 26
Pro-BNP (ng/L) 531.54 ± 45.33 115 ± 13.62 < 0.001*
Echocardiographic data (Rest): Echocardiographic data (Rest): Echocardiographic data (Rest): Echocardiographic data (Rest):
Tricuspid regurge (TR): - Mild - Moderate - Severe 18 (58.06 %) 9 (29.03 %) 4 (12.90 %)
Baffle dysfunction: - Baffle leak - Baffle stenosis 2 (6.45 %) 0 (0 %)
LVOTO 1 (3.23 %)
Pulmonary valve: Stenosis (PS) Regurge (PR) 0 (0 %) 0 (0 %)
RV EDV (ml) 53.95 ± 10.31 43.63 ± 3.87 0.002*
RV ESV (ml) 32.15 ± 9.70 26.63 ± 5.11 0.015*
RV EF Simpson’s (%) 40.13 ± 2.93 53.17 ± 3.17 < 0.001*
TAPSE (mm) 13.81 ± 1.26 17.45 ± 2.93 < 0.001*
2D GLS (%) -11.89 ± 1.31 -22.35 ± 6.73 < 0.001*